NCT05283993
- Conditions
- Abnormalities, Multiple, Amyloidosis, Blood Protein Disorders, +44 more
- Locations
-
- Peking University First Hospital Beijing, China
Clinical trial condition
Monoclonal Gammopathy of Renal Significance (MGRS)
Explore clinical trials studying Monoclonal Gammopathy of Renal Significance (MGRS). Study availability and eligibility vary by location and protocol.
2 public trials
1 recruiting study
Monoclonal Gammopathy of Renal Significance (MGRS) trial results
Not Yet Recruiting
Dara-BCD for Rare MGRS
NCT06771180
- Conditions
- Monoclonal Gammopathy of Renal Significance (MGRS)
- Locations
-
Not specified